3. The detailed classification of T cells in SCLC also revealed the expression pattern of dysfunction and exhaustion markers (such as PDCD1, CTLA4, HAVCR2, LAG3, TIGIT and LAYN), which may be used as immunotherapeutic targets. This evidence concerns the gene TIGIT and small cell lung carcinoma.